In order to assess potential improvement in abnormal left ventricular (LV) wall motion, eighteen subjects sixteen with obstructive coronary artery disease and LV asynergy and two with no evidence of organic heart disease were studied by cardiac catheterization and cineangiography. Ventriculograms were performed at rest and during a constant infusion of l-epinephrine (EPI) at 1-4 ,gg/min after an average of nine minutes steady state. EPI infusion induced augmentation of LV contraction pattern in both normal subjects and in all normal zones in the sixteen subjects with asynergy, and in no instance was contraction in a normal zone rendered abnormal. Eleven of sixteen patients showed improved contraction in previously asynergic areas, two of whom also demonstrated paradoxical motion in an abnormal zone. Of a total of forty-four resting asynergic zones, twenty-three exhibited an improved contraction pattern with EPI, one showed depressed contraction, two demonstrated both an increase and deterioration in the same zone (paradoxical motion), and eighteen showed no change. Quantitative motion analysis generally corroborated these qualitative ventriculographic observations. Heart rate, LV systolic pressure and LV end-diastolic pressure increased slightly with EPI, but were not significantly changed from control values. While there was wide variation in end-diastolic volume in the subjects with asynergy, EPI resulted in an increase in both stroke volume and ejection fraction, the latter significantly (P < 0.05). In the four subjects who subsequently underwent aneurysmectomy, preoperative lack of improvement with EPI correlated with a pathologic diagnosis of fibrosis. Other than angina pectoris of brief duration in two subjects, EPI provoked no untoward reactions, arrhythmias or complications. It is concluded that LV motion abnormalities can be improved or changed in certain cases by the inotropic stimulus of EPI, suggesting residual contractile ability; the agent may differentiate between zones of potentially functional cardiac muscle and frank fibrosis.
SUMMARY
In order to assess potential improvement in abnormal left ventricular (LV) wall motion, eighteen subjects sixteen with obstructive coronary artery disease and LV asynergy and two with no evidence of organic heart disease were studied by cardiac catheterization and cineangiography. Ventriculograms were performed at rest and during a constant infusion of l-epinephrine (EPI) at [1] [2] [3] [4] ,gg/min after an average of nine minutes steady state. EPI infusion induced augmentation of LV contraction pattern in both normal subjects and in all normal zones in the sixteen subjects with asynergy, and in no instance was contraction in a normal zone rendered abnormal. Eleven of sixteen patients showed improved contraction in previously asynergic areas, two of whom also demonstrated paradoxical motion in an abnormal zone. Of a total of forty-four resting asynergic zones, twenty-three exhibited an improved contraction pattern with EPI, one showed depressed contraction, two demonstrated both an increase and deterioration in the same zone (paradoxical motion), and eighteen showed no change. Quantitative motion analysis generally corroborated these qualitative ventriculographic observations. Heart rate, LV systolic pressure and LV end-diastolic pressure increased slightly with EPI, but were not significantly changed from control values. While there was wide variation in end-diastolic volume in the subjects with asynergy, EPI resulted in an increase in both stroke volume and ejection fraction, the latter significantly (P < 0.05). In the four subjects who subsequently underwent aneurysmectomy, preoperative lack of improvement with EPI correlated with a pathologic diagnosis of fibrosis. Other than angina pectoris of brief duration in two subjects, EPI Each ventriculogram was interpreted qualitatively for determination of which areas were asynergic. Asynergy was defined as localized abnormalities of ventricular wall motion and was classified as akinesis, a total lack of motion; dyskinesis, paradoxical systolic expansion of a zone; or local hypokinesis, decrease in the expected local motion.' In addition, quantitative angiographic methods were employed to obtain volum. es and ejection fractions, utilizing modifications of the method of Dodge et al.6 Segmental motion analysis was accomplished by calculating the conventional major and minor axes, as previously described by this laboratory and illustrated in figures 6-9.6 These figures are graphic illustrations of ventricular silhouettes in the 30-degree right anterior oblique projection in the resting and epinephrine state; the arrows indicate the change in ventricular dimensions from end-diastole to end-svstole; and, the major and minor axes, L and D1-D3 respectively, are shown with their respective values listed for percent shortening from end-diastole to end-systole. The apex and mid-aortic valve were used as fixed reference points.
In the present study both qualitative and quantitative motion analyses were confined to the right anterior oblique projection. The septal and posterolateral zones seen in the left anterior oblique view are rarely asynergic without corresponding involvement of either the anterior, apical, or inferior zones in the right anterior oblique view.3
The data were analyzed by the paired t-test.
Results

Qualitative Analysis of Ventricular Asynergy
The qualitative results are demonstrated in figure 1 and described in table 1 When analyzed in terms of the total of sixty-four zones, twenty-three of forty-four areas of asynergy exhibited an improved contraction pattern with epinephrine, one showed depressed contraction, two demonstrated both an increase and deterioration in the same zone (paradoxical motion), and eighteen showed no change. The single zone with depressed contraction was part of a paradoxical expansile motion induced by ephinephrine (patient HFB.). All normal zones at rest had augmented contraction with epinephrine. Asynergy of the basal region was not observed, and in all cases epinephrine increased the vigor of basal contraction. The other four normal resting zones were all inferior in location and all demonstrated enhanced contraction (table 1). None of these four subjects had obstructive disease in coronary arteries supplying the inferior surface of the left ventricle.
H-emodynamics
The effects of epinephrine on heart rate, left ventricular systolic pressure and left ventricular enddiastolic pressure are summarized in table 2 and illustrated in figure 2. In both the normal subjects and the patients with coronary artery disease in whom these measurements were available, all three variables left ventricular end-diastolic pressure showed little change with epinephrine in most patients, a striking increase was noted in two of the subjects with coronary artery disease, both of whom (J. H. and H. M.) developed angina pectoris at the time.
Volume Studies Table 2 and figure 3 demonstrate the effects of epinephrine on the quantitative angiographic variables, end-diastolic volume, stroke volume, and ejection fraction. In the two normal subjects minimal changes occurred in end-diastolic volume while stroke volume and ejection fraction increased. While there was wide variation in end-diastolic volume in the coronary artery disease group, epinephrine infusion resulted in an increase in both stroke volume and ejection fraction, the latter significantly (P < 0.05). Despite these directional changes in stroke volume and ejection fraction as a group, there was considerable individual variation. No change occurred in ejection fraction in some patients who nevertheless Figure 6 , in contrast, represents a patient with coronary disease in whom epinephrine induced augmentation of contraction in a previously asynergic zone. Note the striking improvement in the area of anteroapical hypokinesis with attendant improvement in normal zones as well. This is well supported by the augmented shortening of D3 and L axes. There was a marked increase in ejection fraction from 0.25 to 0.55 in this subject. 4 . Figure 7 illustrates both improvement and deterioration of contraction in the same patient induced by epinephrine. Note the augmented contraction in the areas of high anterior and inferior hypokinesis but with exaggeration of the degree of anterior dyskinesis. The latter is illustrated by the outgoing arrows and axis lengthening. Ejection fraction in this case changed from 0.31 to 0.36. Table 3 describes the intraoperative observations and tissue diagnosis, where available, of the thirteen patients who underwent cardiac surgery for their coronary artery disease.
Intraoperative and Pathological Observations
Of the six subjects who showed improvement with epinephrine in a zone of asynergy, all showed normal muscular contraction in this zone at the time of operation, 4 with apparently normal muscle and 2 with a mixture of muscle and fibrosis on inspection. Of the 7 patients who showed no improvement in asynergy with epinephrine 6 were observed to have a frank thin REST EPINEPHRINE % AXIS SHORTENING Earlier studies in this laboratory have defined and classified disturbances in left ventricular wall motion (asynergy), and have elucidated their contribution to ventricular dysfunction in coronary artery disease. In examining the defects responsible for asynergy it was found that, in some cases, there is replacement of ventricular muscle by fibrous scar. In others, normal muscle is interspersed with fibrosis, and in some cases muscle may be structurally normal but fails to shorten for a variety of reasons. laboratory must be considered, such as the administration of radiographic contrast agent, sedative drugs, and other aspects of the catheterization procedure itself.
The potential reversibility of depression and asynergy of the ischemic myocardium is of considerable practical importance. In the setting of acute experimental ischemia, hypokinesis and paradoxical systolic expansion consistently occur after temporary occlusion of the coronary artery, and motion of the hypoxic myocardium is recovered if the occlusion is promptly removed.8' 9 Furthermore, in man, it has been reported that coronary artery bypass graft surgery in the preinfarction syndrome improved marked left ventricular hypokinesis and akinesis, along with ejection fraction and other derived indices of myocardial contractility.'0 Similar results have been reported in chronic stages of ischemic heart disease where persistent alterations may exist in one area of the ventricle due to frank fibrosis, while other areas of myocardium may be reversibly damaged and capable of improvement if blood flow is restored. In one study of ventricular wall motion following aortocoronary venous bypass surgery, 51% (19 of 37) of deficits of ventricular wall motion were improved following surgery. In this study hypokinesis was improved in 70% (17 out of 24 instances) with a normal contraction restored in nearly one-half of the cases; but akinesis was improved in only 15% (2 out of 13 instances.)" Bourassa has recently summarized postoperative experience and concluded that revascularization does not necessarily improve left ventricular function. 12 Presumably restoration of function might be possible although not proven if the zone of asynergy was composed of muscle or muscle interspersed with fibrosis. Frank aneurysm and scar would not be expected to improve.
What is required is some means to predict beforehand which portions of the ischemic left ventricle are potentially capable of improvement. Various June 1974 interventions have been employed during cineventriculography to better define wall motion abnormalities in coronary artery disease, and in particular to provoke potential areas of asynergy not present at rest. This has been termed "stress ventriculography." One example is the induction of temporary segmental ischemia by atrial pacing; this study demonstrated that major abnormalities of segmental motion of the wall of the ventricle may be induced by the ischemic stress of an increased heart rate.2 In another study, propranolol, or a beta-adrenergic blocking agent was shown to induce or accentuate zones of asynergy, presumably by causing a certain degree of myocardial depression.' Present Study
In the present study, however, the objective was to determine if segmental and/or global left ventricular contraction pattern could be improved if abnormal at rest. Thus, a mechanism to augment contraction was required, and the agent selected was l-epinephrine. This is a positive inotropic agent which increases cardiac output, stroke volume, and systolic ejection rate without a significant change in blood pressure or heart rate;4 and, acting as a secondary coronary vasodilator, it increases coronary blood flow.4 It was felt that 1-epinephrine might be a safer agent in the heart of subjects with coronary artery disease because it increases inotropic state while lacking the primary coronary vasoconstrictor effect of norepinephrine'3 and the potentially marked chronotropic and peripheral vasodilating effect of isoproterenol. "4 In a human study such as this the problems inherent in the methodology and approaches must be recognized. is ± 0.05 and + 27 ml, respectively in our laboratory. 23 In our study the positive inotropic effects of epinephrine on wall motion are well demonstrated by the augmented or hyperdynamic contraction pattern of the entire left ventricle in the normal subjects and of all normal zones in the sixteen subjects with asynergy. In no instance was contraction in such a normal zone rendered abnormal. Eleven of sixteen subjects showed improved contraction in twenty-three of forty-four asynergic areas. Two of these eleven patients also demonstrated paradoxical motion in an abnormal zone. These effects on contraction pattern were achieved without a significant change in heart rate, left ventricular systolic pressure or left ventricular end-diastolic pressure, confirming previous hemodynamic studies. 4 And in six subjects preoperative lack of improvement with epiniephrine correlated with a pathologic diagnosis of myocardial fibrosis or frank aneurysm.
Animal studies of the differential effect of catecholamines on ischemic and nonischemic portions of myocardium showed that although the nonischemic myocardium responded to norepinephrine, metaraminol and isoproterenol with augmented contraction, the ischemic zone showed an increase in the amplitude of paradoxical systolic expansion.24 Similar results were found in another study of acute ischemia in dogs in which the systemic administration of the inotropic agents, isoproterenol and calcium, increased the degree of early systolic bulging with some augmentation of later shortening. 25 Insufficient time has elapsed since this study was initiated to permit any definitive statements regarding the subjects who underwent surgery and their postoperative ventricular function and contraction pattern. Therefore, it remains to be determined whether this particular intervention, the "epinephrine ventriculogram," will provide a preoperative means of defining the potential benefit of revascularization surgery on left ventricular contraction.
However, the data from this study do strongly support the transient clinical use of epinephrine as a safe inotropic agent in ischemic heart disease, not only where hemodynamic improvement is necessary, but especially in those situations where ventricular asynergy may be an important factor. For example, patients with extensive left ventricular asynergy are known to be at higher than average risk during cardiac surgery;27 whether or not augmentation of left ventricular wall motion in such patients will correlate with improved prognosis is currently being investigated.
